American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

Author:

Middeldorp Saskia1ORCID,Nieuwlaat Robby23,Baumann Kreuziger Lisa4ORCID,Coppens Michiel56ORCID,Houghton Damon78ORCID,James Andra H.9ORCID,Lang Eddy10ORCID,Moll Stephan11ORCID,Myers Tarra12,Bhatt Meha2,Chai-Adisaksopha Chatree13,Colunga-Lozano Luis E.14ORCID,Karam Samer G.23ORCID,Zhang Yuan12ORCID,Wiercioch Wojtek23ORCID,Schünemann Holger J.2315ORCID,Iorio Alfonso3ORCID

Affiliation:

1. 1Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

2. 2Michael G. DeGroote Cochrane Canada and MacGRADE Centres, McMaster University, Hamilton, ON, Canada

3. 3Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

4. 4Department of Medicine, Division of Hematology & Oncology, Versiti Blood Research Institute, Versiti and Medical College of Wisconsin, Milwaukee, WI

5. 5Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

6. 6Pulmonary Hypertension and Thrombosis, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands

7. 7Division of Vascular Medicine, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN

8. 8Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

9. 9Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC

10. 10Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

11. 11Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC

12. 12Cambridge, ON, Canada

13. 13Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

14. 14Health Science Center, Universidad de Guadalajara, Guadalajara, Mexico

15. 15Institut für Evidence in Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany

Abstract

Background Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial. Objective These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about thrombophilia testing. Methods ASH formed a multidisciplinary guideline panel covering clinical and methodological expertise and minimizing bias from conflicts of interest. The McMaster University GRADE Centre provided logistical support, performed systematic reviews, and created evidence profiles and evidence-to-decision tables. The Grading of Recommendations Assessment, Development, and Evaluation approach (GRADE) was used. Recommendations were subject to public comment. Results The panel agreed on 23 recommendations regarding thrombophilia testing and associated management. Nearly all recommendations are based on very low certainty in the evidence due to modeling assumptions. Conclusions The panel issued a strong recommendation against testing the general population before starting combined oral contraceptives (COCs) and conditional recommendations for thrombophilia testing in the following scenarios: (a) patients with VTE associated with nonsurgical major transient or hormonal risk factors; (b) patients with cerebral or splanchnic venous thrombosis, in settings where anticoagulation would otherwise be discontinued; (c) individuals with a family history of antithrombin, protein C, or protein S deficiency when considering thromboprophylaxis for minor provoking risk factors and for guidance to avoid COCs/hormone replacement therapy; (d) pregnant women with a family history of high-risk thrombophilia types; and (e) patients with cancer at low or intermediate risk of thrombosis and with a family history of VTE. For all other questions, the panel provided conditional recommendations against testing for thrombophilia.

Publisher

American Society of Hematology

Subject

Hematology

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3